I-TRACKER
LIVE

Serial Number

79289073

Owner

THERADIAG SA.

Attorney

Cecilia R. Dickson

Filing Date

Mar 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

I-TRACKER Trademark

Serial Number: 79289073 • Registration: 6358437

I-TRACKER is a trademark filed by THERADIAG SA. on March 4, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

THERADIAG SA.

14 rue Ambroise Croizat

Entity Type: 98

Theradiag

14 rue Ambroise Croizat

Entity Type: 33

Biosynex

22 boulevard Sébastien Brant

Entity Type: 98

Trademark Details

Filing Date

March 4, 2020

Registration Date

May 25, 2021

Published for Opposition

March 9, 2021

Goods & Services

Medical diagnostic instruments in the nature of automated analyzers for body fluids for medical use; measuring apparatus for medical diagnostic use, namely, devices for measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; medical diagnostic apparatus for medical use, namely, blood testing apparatus, immunochemical testing apparatus; medical diagnostic testing apparatus for immunoassay procedures; blood testing apparatus for medical use; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for the analysis of body fluids; testing apparatus for medical use, namely, blood testing apparatus, immunochemical testing apparatus; apparatus for analysis of substances for medical use, namely, apparatus for blood analysis for medical purposes; apparatus for conducting diagnostic tests for medical use, namely, medical diagnostic apparatus for the analysis of body fluids and for detecting antibodies; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for the analysis of body fluids; diagnostic, testing and monitoring equipment, namely, medical diagnostic apparatus for analysis of body fluids and detecting and monitoring antibodies; medical diagnostic instruments for the analysis of body fluids; testing instruments for use in medical diagnosis, namely, blood testing apparatus, immunochemical testing apparatus; electrical instruments for medical use for blood diagnosis; medical diagnostic-test instruments for immunoassay procedures

Diagnostic preparations for scientific use; diagnostic preparations for scientific use or for research; chemical preparations for use in scientific diagnosis; laboratory chemical preparations for scientific use; diagnostic preparations for scientific use; products for diagnosis for scientific use, namely, diagnostic reagents and assays; products for diagnosis intended for scientific use, namely, diagnostic reagents and assays; diagnostic reagents for scientific use; diagnostic reagents for in-vitro use for biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific use or for research; laboratory reagents for scientific use; universal reagents for automated laboratory testing systems; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical substances for laboratory use, other than for medical or veterinary purposes; chemicals for use in industry and science

Biotechnological preparations for medical use, namely, reagent and assays for in vitro diagnostic; chemical preparations for medical use for blood analysis; diagnostic preparations for medical use; diagnostic preparations for medical or veterinary use; in-vitro diagnostic preparations for medical use; diagnostic kits consisting of medical diagnostic reagents and assays for testing bodily fluid; analytical reagents for medical use; chemical reagents for medical use; chemical reagents for medical diagnosis; diagnostic biomarking reagents for medical use; diagnostic reagents for medical use; clinical diagnostic reagents; reagents and substances for medical and veterinary diagnostic purposes; immunological reagents for medical use; reagents for analysis for medical use; reagents for medical diagnosis; reagents for diagnostic tests for medical use; reagents for in vitro use in laboratories for medical use; diagnostic substances for medical use; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents for medical use sold as kits

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 25, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Feb 27, 2025 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 31, 2025 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Oct 11, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 16, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 31, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 17, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 17, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 25, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
May 25, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 9, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 28, 2020 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2020 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 17, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 17, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 17, 2020 COAR
REFUSAL PROCESSED BY IB
Sep 5, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 20, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 20, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 15, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jul 14, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 14, 2020 MAFR
ASSIGNED TO EXAMINER
Jul 10, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 9, 2020 REPR